| Stage | ALHC | % of rev | UNH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $113B | 100.00% | UNH ×84.37 |
| Gross profit | $1.3B | 100.00% | $22.0B | 19.53% | ALHC +80.5pp |
| Operating income | $42M | 3.15% | $6.6B | 5.82% | UNH +2.7pp |
| Pre-tax income | $38M | 2.83% | $5.5B | 4.90% | UNH +2.1pp |
| Net income | $37M | 2.74% | $4.3B | 3.82% | UNH +1.1pp |
| Stage | ALHC | UNH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $113B100.00% | UNH ×84.37 |
| Gross profit | 100.00%$1.3B | 19.53%$22.0B | ALHC +80.5pp |
| Operating income | 3.15%$42M | 5.82%$6.6B | UNH +2.7pp |
| Pre-tax income | 2.83%$38M | 4.90%$5.5B | UNH +2.1pp |
| Net income |
| 2.74%$37M |
| 3.82%$4.3B |
| UNH +1.1pp |
None
No disclosed counterparties: ALHC.